… In recent years, lung cancer incidence and mortality of cancer at first, but the vast majority
of patients in the first option is already late, loses the chance of radical surgery treatment, …

… first-line treatment with gefitinib plus FZKA conferred longer PFS and MST than treatment
with gefitinib … Gefitinib or chemotherapy for nonsmall-cell lung cancer with mutated EGFR. N …

… gefitinib versus chemotherapy as the first-line treatment for the patient with advanced non-squamous
cell lung cancer … non-squamous non-small cell lung(NSCLC),we evaluated the …

… advanced non-small cell lung cancer who had failed to previous first-line chemotherapy …
growth factor receptor mutation in non-small-cell lung cancer patients treated with gefitinib[J]. J …

… Gefitinib therapy on patients with advanced non-small cell … Gefitinib versus Erlotinib as
first-line treatment for patients with advanced EGFR mutationpositive non-small-cell lung cancer[J]…

… 誗含铂双药方案是晚期非小细胞肺癌(nonsmall cell lung cancer… ) as a first-line treatment for
never-smokers with advanced or … Gefitinib or chemotherapy for non-small-cell lung cancer with …

… for the first-line treatment of non-small cell lung cancer (NSCLC… However, some patients
fail to benefit from this treatment. … -TKIs versus chemotherapy as first-line treatments of NSCLC …

… -TKI) significantly benefits advanced non-small cell lung cancer (… EGFR mutations taking
EGFR-TKI as a first-line therapy. … in efficacy between gefitinib and erlotinib, and gefitinib is safer …

… of gefitinib combined with chemotherapy on … )advanced non-small cell lung cancer patients
with active epidermal growth factor receptor mutations receiving first-line gefitinib therapy: a …